Kim, Y., & Shin, D. (2023). CLINICAL RESULTS OF LONG-TERM LOBEGLITAZONE ADD-ON THERAPY IN TYPE 2 DIABETES. Journal of the ASEAN Federation of Endocrine Societies, 38(S3), 71–72. https://doi.org/10.15605/jafes.038.AFES.108